The global hematology analyzers and reagents market is poised for steady expansion over the next decade, projected to grow from USD 6.96 billion in 2025 to USD 11.78 billion by 2034 , representing a compound annual growth rate (CAGR) of 6.0% during the forecast period. In 2024, the market was valued at USD 6.57 billion . This growth is fueled by the increasing global focus on clinical diagnostics , the rising burden of chronic and infectious diseases, and technological advancements in automated hematology systems . As healthcare shifts toward precision, speed, and scalability, hematology testing plays an increasingly critical role in both centralized labs and point-of-care testing environments. Market Overview Hematology analyzers and reagents are essential components of modern clinical laboratories, used primarily for complete blood count (CBC) and other blood-related diagnostic tests. The...